rare diseases clinical research network
The rare disease data center reduces diagnostic time by over 60% by aggregating multi-omic data in a single platform, allowing clinicians to pinpoint pathogenic variants in weeks rather than months. This centralized hub links genomics, electronic health records, and patient-reported outcomes, creating a living map of rare conditions. By collapsing
rare disease research labs
Alexion’s rare disease data center cuts trial dropout by 60% for newly launched therapies. By integrating the 2026 AAN dataset, the platform identifies patient subgroups that stay in studies longer. This results in faster trial readouts and more reliable efficacy signals. Medical Disclaimer: This article is for informational purposes
rare diseases clinical research network
Integrating Illumina sequencing with CD2B analytics cuts pediatric rare-cancer trial recruitment by 40 percent, shrinking the enrollment window dramatically. The acceleration comes from real-time variant calling and automated phenotype matching. Clinicians can move from sample to trial arm in days instead of weeks, per Illumina and CD2B internal analysis. Medical
rare disease data center
The Rare Disease Data Center aggregates genomic data from 120,000 patients, cutting variant-calling time by 70% and saving laboratories millions of dollars each year. By unifying sequences, phenotypes, and regulatory markers, the center turns fragmented data into a single, auditable pipeline. The result is faster research, lower testing waste,